Raslan, Heba Y.
Faisal, Waleed
Abdellah, Noura H.
Abouelmagd, Sara A.
Ibrahim, Elsayed A.
Article History
Received: 2 May 2025
Accepted: 3 July 2025
First Online: 20 July 2025
Declarations
:
: This study was approved by Assiut University Research Ethics Committee. The committee revised and approved the study protocol under approval number 05–2023-021. Participation in the online surveys was voluntary, and consent was implied by completing the questionnaire. Participants were assured of confidentiality and informed that aggregated results would be disseminated to all contributors.
: Consent for publication was secured by informing contributors that anonymized results would be publicly disseminated.
: The authors declare the following competing interest: W.F. is a founder and CEO of ArrayPatch Ltd., a company involved in the commercialization of dissolvable microneedle-based drug products.